Researchers have identified a mechanism by which metastatic breast cancer evades the immune system. This discovery involves the interplay of metabolic, epigenetic, and immune factors, and may have implications for the development of new therapies. The findings shed light on the complex processes that allow dormant cancer cells to become metastases and how they resist treatment.